Floatz logo

Eltrombopag

Thrombocytopenia

Institute of Hematology & Blood Diseases Hospital, ChinaSmall moleculePhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
89/ 100

Competitive context

17 Active assets in the Thrombocytopenia cohort.

Asset / SponsorPhaseRating
Recombinant Human Thrombopoietin
Sun Yat-sen University
Phase 4BBB
Avatrombopag
Second Affiliated Hospital of Guangzhou Medical University
Phase 4BB
FILGRASTIM
OHSU Knight Cancer Institute
Phase 2BB
Hetrombopag
Sun Yat-sen University
Phase 3BB
CYTARABINE
OHSU Knight Cancer Institute
Phase 2BB

View all 50 →

Same molecule, other indications

Eltrombopag is also rated in:

acute myeloid leukemiaActive
B
Indicative · Phase 2/3
56 / 100
View asset →
liver disorderDormant
B
Indicative · Phase 3
56 / 100
View asset →
hepatitis C virus infectionDormant
B
Indicative · Phase 3
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →